TT
BMY icon

Tower Trust’s Bristol-Myers Squibb BMY Stock Holding History

Tower Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$772K Sell
14,852
-3,559
-19% -$189K 0.49% 58
2013
Q4 		$979K Hold
18,411
– – 0.59% 53
2013
Q3 		$852K Buy
18,411
+596
+3% +$26.2K 0.58% 54
2013
Q2 		$796K Buy
+17,815
New +$773K 0.57% 58

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tower Trust's BMY Position: Q1 2014 in Review

Tower Trust reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q1 2014, selling an estimated $189K and leaving 14,852 shares worth $772K. The position accounts for 0.49% of the portfolio, ranked #58.

Tower Trust first reported a position in BMY in Q2 2013 and has held it in 4 quarters since. The position peaked at $979K in Q4 2013. 1,328 funds tracked by Wall St. Rank hold BMY as of Q1 2014.

  • Tower Trust held 14,852 shares of Bristol-Myers Squibb worth $772K as of Q1 2014.
  • Tower Trust sold 3,559 Bristol-Myers Squibb shares in Q1 2014, an estimated $189K.
  • Bristol-Myers Squibb made up 0.49% of Tower Trust's portfolio in Q1 2014, its #58 holding.
  • Tower Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 4 quarters since.
  • Tower Trust's Bristol-Myers Squibb position peaked at $979K in Q4 2013.
  • 1,328 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2014.

Based on Tower Trust's 13F filing for Q1 2014, filed 8 May 2014.